- Optimization of pregravidare training of women with hysteromyoma
Optimization of pregravidare training of women with hysteromyoma
HEALTH OF WOMAN. 2017.7(123):59–60; doi 10.15574/HW.2017.123.59
Dovgan A. A.
National Medical Academy of Postgraduate Education P. L. Shupyk, Kiev
The objective: to improve tactics of pregravidare training of women with hysteromyoma.
Patients and methods. Under observation there were 100 patients of active and late genesial age (from 22 to 44 years), with the main diagnosis hysteromyoma established on the basis of complex inspection. To all patients the conservative myomectomy by laparotomny that laparoscopic accesses out of pregnancy was made, a course of complex rehabilitational therapy in the early and late postoperative period is conducted, the next and remote results are tracked.
Results. Efficiency of pregravidarny training of patients with a hysteromyoma made 67.0%, thus authentically larger frequency of offensive of pregnancy is noted in group of the patients receiving in the postoperative period therapy by agonists of GNRG (73.0%), including at women with genesial problems (52.0%). Besides, purpose of agonists of GNRG after operation allows to reduce number of recurrence of a disease in the remote period.
Conclusions. The advanced technique of pregravidarny preparation allows to improve the genesial forecast of women with hysteromyoma.
Key words: hysteromyoma, pregravidarny preparation, optimization.
1. Adamyan LV, Zarubiani ZR, Kiselyov SI. 2012. A laparoscopy and a gisterorezectoscopia in surgical treatment of a hysteromyoma at women of genital age. Obstetrics and gynecology 3:40–44.
2. Bazanov PA, Volkov NI. 2012. Hysteromyoma and disturbances of genesial function. Reproduction Problems 4;8:16–18.
3. Buyanova SN, Logutov LS, Babunashvili EL. 2013. The genesial forecast at hysteromyoma. Russian messenger of the obstetrician-gynecologist 3;4:47–9.
4. Vikhlyaeva EM. 2010. About strategy and tactics of maintaining patients with a hysteromyoma. Messenger of the Russian association of obstetricians-gynecologists 3:21–2.
5. Andersen J. 2010. Growth factors and cytokines in uterine leiomyomas. Semin Reprod Endocrinol 14(3):269–82. https://doi.org/10.1055/s-2007-1016336; PMid:8885057
6. Candiani GB, Fedele L. 2011. Risk of recurrence after myomectomy. Br J Obstet Gynaecol 98(4):385–9. https://doi.org/10.1111/j.1471-0528.1991.tb13429.x
7. Fauconnier A, Chapron C. 2010. Recurrence of leiomyomata after myomectomy. Human Reproduction Update 6(6):595–602. https://doi.org/10.1093/humupd/6.6.595